PI

Pennant Investors Portfolio holdings

AUM $334M
1-Year Return 56.91%
This Quarter Return
+17.04%
1 Year Return
+56.91%
3 Year Return
+148.85%
5 Year Return
+226.03%
10 Year Return
–
AUM
$362M
AUM Growth
+$36.3M
Cap. Flow
-$11.8M
Cap. Flow %
-3.26%
Top 10 Hldgs %
95.42%
Holding
45
New
2
Increased
1
Reduced
3
Closed
1

Top Buys

1
ENOV icon
Enovis
ENOV
+$25M
2
AR icon
Antero Resources
AR
+$6.38M

Top Sells

1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$26.6M
2
AMZN icon
Amazon
AMZN
+$9.38M
3
MSFT icon
Microsoft
MSFT
+$7.15M
4
TVTX icon
Travere Therapeutics
TVTX
+$502K

Sector Composition

1 Technology 23.03%
2 Consumer Discretionary 20.63%
3 Communication Services 16.79%
4 Industrials 14.41%
5 Healthcare 11.22%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ZYME icon
26
Zymeworks
ZYME
$1.21B
$407K 0.1%
38,700
– –
CHRS icon
27
Coherus Oncology, Inc. Common Stock
CHRS
$158M
$402K 0.1%
168,100
– –
CMPX icon
28
Compass Therapeutics
CMPX
$637M
$394K 0.1%
199,000
– –
RLAY icon
29
Relay Therapeutics
RLAY
$726M
$352K 0.09%
42,400
– –
ERAS icon
30
Erasca
ERAS
$488M
$342K 0.08%
166,200
– –
SAGE
31
DELISTED
Sage Therapeutics
SAGE
$328K 0.08%
17,500
– –
NVAX icon
32
Novavax
NVAX
$1.39B
$288K 0.07%
60,300
– –
AGEN
33
Agenus
AGEN
$144M
$272K 0.07%
23,480
– –
QURE icon
34
uniQure
QURE
$801M
$252K 0.06%
48,500
– –
REPL icon
35
Replimune Group
REPL
$454M
$249K 0.06%
30,500
– –
BTAI icon
36
BioXcel Therapeutics
BTAI
$48.5M
$237K 0.06%
5,244
– –
ALLK
37
DELISTED
Allakos
ALLK
$234K 0.06%
186,100
– –
MCRB icon
38
Seres Therapeutics
MCRB
$151M
$226K 0.06%
14,615
– –
KLRS
39
Kalaris Therapeutics, Inc. Common Stock
KLRS
$93.3M
$163K 0.04%
9,378
– –
MIMO
40
DELISTED
Airspan Networks Holdings Inc.
MIMO
$118K 0.03%
1,047,473
– –
BLUE
41
DELISTED
bluebird bio
BLUE
$112K 0.03%
4,370
– –
GRABW icon
42
Grab Holdings Limited Warrant
GRABW
$13.8M
$16.2K ﹤0.01%
80,000
– –
AAPL icon
43
Apple
AAPL
$3.55T
– –
0
– –
TVTX icon
44
Travere Therapeutics
TVTX
$2.04B
– –
-55,800
Closed -$502K
1
2